Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …

News

Shooting for the moon: The National Cancer Institute’s Formulary

June 16, 2017
Medical Communications, Research and Development NCI

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

News
sunbathing-1207930_960_720

Drug that induces tanning could protect against melanoma

June 16, 2017
Medical Communications, Research and Development melanoma, skin cancer, sun

People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …

News
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017
Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …

News
fda_sign_web

New rival to EpiPen receives FDA approval to shake up market

June 16, 2017
Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen

Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …

News
roche__tree

From pipeline to patients: Navigating treatments through the UK system

June 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline

Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …

Feature
aedes_aegypti_mosquito

Weakness discovered in malaria parasite could lead to new treatment

June 15, 2017
Protein, anti-malarial drug resistance, malaria, mosquito

A protein has been newly discovered that could lead to an alternative form of vaccination against the spread of malaria …

News
fda2outsideweb

FDA fast-tracks Pfizer and Lilly’s chronic pain drug

June 15, 2017
Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer

Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …

News
pharma_pill_manufacturing

EMA lags behind FDA on continuous manufacturing regulation

June 15, 2017
Manufacturing and Production EMA, FDA, continuous manufacturing

Continuous manufacturing is increasingly an area of fixation within the pharma industry for the benefits it can bring to the …

News

Novartis’ Cosentyx shines in ankylosing spondylitis and psoriatic arthritis

June 15, 2017
Research and Development Cosentyx, Novartis

Novartis has released new data on the efficacy of its drug Cosentyx (secukinumab) in the treatment of life-long inflammatory diseases …

News
microscope-275984_960_720

LifeArc rebrands and sets up £500m research fund

June 15, 2017
Medical Communications, Research and Development, Sales and Marketing LifeArc, MRC Technology, keytruda

The UK medical research charity formerly known as MRC Technology has rebranded to be known as LifeArc. At the same …

News
credit-_pdxnative

Trump appoints new Director of the National Cancer Institute

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment

Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …

Appointment

PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance

Guildford, UK 14th  June, 2017

News
Press release
1491927276280

Alexion secures ex-Biogen Chief Financial Officer

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment

Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …

Appointment
vaccination-1215279_960_720

Bhutan and Maldives successfully eliminate measles

June 14, 2017
Medical Communications, Research and Development WHO, immunisation, measles, rubella

The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …

News
celltrion1

Celltrion biosimilar proves effectiveness in lymphoma and rheumatoid arthritis

June 14, 2017
Research and Development Cellltrion, Truxima, biosimilar, lymphoma, rheumatoid arthritis, rutiximab

Celltrion Healthcare has revealed new data which validates its biosimilar Truxima (CT-P10) as non-inferior to its reference product rituximab in …

News
vaccine

Reversal of type 1 diabetes possible through century-old vaccine

June 14, 2017
Research and Development BCG, Type 1 diabetes, Vaccine, diabetes

The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …

News

FDA to review effectiveness of abuse deterrent opioid drugs

June 14, 2017
Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid, opioid crisis

FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …

News
dna

Genetic test reveals at-risk men for testicular cancer

June 14, 2017
Research and Development ICR, Movember Foundation, testicular cancer

Research emerging from the Institute of Cancer Research has revealed the men most statistically at-risk of developing testicular cancer. The …

News
doug_manion

BMS vet joins Kleo Therapeutics as CEO

June 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Kleo Pharmaceutical

Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …

Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026